Skip to Main Content

Paper Details

Fisetin for COVID-19 in skilled nursing facilities: Senolytic trials in the COVID era.
J Am Geriatr Soc
34
2021
COVID, COVID-19, Fisetin, SARS-CoV, SARS-CoV-2, SASP, SNFs, SnCs, cardiovascular, kidney, and lung diseases, chronic, chronic diseases, diabetes, frailty, human, multiorgan failure, multiple, obesity, osteoporosis, patients, respiratory diseases, senescent cells
Author NameAffiliation
Elizabeth J AtkinsonMayo Clinic
Stephen B KritchevskySticht Center for Healthy Aging and Alzheimer's Prevention
Sundeep KhoslaMayo Clinic
Sundeep KhoslaMayo Clinic
Douglas P KielHinda and Arthur Marcus Institute for Aging Research
Douglas P KielHarvard Medical School
Douglas P KielBeth Israel Deaconess Medical Center
Douglas P KielHinda and Arthur Marcus Institute for Aging Research
Douglas P KielBeth Israel Deaconess Medical Center
Douglas P KielHarvard Medical School
Michael A PuskarichInstitute on the Biology of Aging and Metabolism, University of Minnesota
Laura J NiedernhoferInstitute on the Biology of Aging and Metabolism, University of Minnesota
Paul D RobbinsInstitute on the Biology of Aging and Metabolism, University of Minnesota
  • 1 - 13

Datasets

Release 1.2